The Scientist

» rare diseases and genetics & genomics

Most Recent

image: Reducing Gene Therapy-Related Risk

Reducing Gene Therapy-Related Risk

By | January 22, 2015

In a mouse model of a rare disease, scientists have figured out how to reduce the elevated cancer risk tied to a gene therapy treatment.


image: GMO “Kill Switches”

GMO “Kill Switches”

By | January 21, 2015

Scientists design bacteria reliant upon synthetic amino acids to contain genetically modified organisms.


image: Fraction of SNPs Can Affect Fitness

Fraction of SNPs Can Affect Fitness

By | January 21, 2015

A point mutation analysis of the entire human genome finds that alterations to as many as 7.5 percent of nucleotides may have contributed to humans’ evolutionary split from chimpanzees.

1 Comment

image: Tracking Tuberculosis Over Time

Tracking Tuberculosis Over Time

By | January 19, 2015

Genomic analysis of a multidrug-resistant lineage pinpoints historical correlations with human events.


image: 23andMe Partners with Pfizer

23andMe Partners with Pfizer

By | January 13, 2015

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

1 Comment

image: Genome Digest

Genome Digest

By | January 12, 2015

What researchers are learning as they sequence, map, and decode species’ genomes


image: Corn Chronicle

Corn Chronicle

By | January 8, 2015

A genetic analysis of ancient and modern maize clarifies the crop’s checkered domestication history.


image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: 23andMe, Genentech Partner on Parkinson’s

23andMe, Genentech Partner on Parkinson’s

By | January 7, 2015

Firms enter a multi-year deal for the analysis of whole-genome sequence data, with an eye toward drug discovery for Parkinson’s disease.


image: Custom Creatures?

Custom Creatures?

By | January 6, 2015

San Francisco-based biotech wants to see its technology applied for inventing new organisms.


LI-COR Biosciences
LI-COR Biosciences

Popular Now

  1. Antidepressant Exerts Epigenetic Changes
  2. Inside a Lab Mouse’s High-Fat Diet
  3. Image of the Day: Mother’s Love
  4. Gut Bugs to Brain: You’re Stuffed
Life Technologies